Historical shareholding details of
Calamos Advisors LLC
holdings in Vertex Pharmaceuticals, Inc. (VRTX)
Monthly changes of
Calamos Advisors LLC
shareholding in Vertex Pharmaceuticals, Inc.
over the previous
months
Month
|
Name |
Total no. shares held |
Percent Holding |
Mar 31, 2025
|
Calamos Advisors Llc
|
48,987
|
0.02%
|
|
Feb 28, 2025
|
Calamos Advisors Llc
|
48,987
|
0.02%
|
|
Jan 31, 2025
|
Calamos Advisors Llc
|
48,987
|
0.02%
|
|
Dec 31, 2024
|
Calamos Advisors Llc
|
45,244
|
0.02%
|
Dec 31, 2024
|
Calamos Advisors Llc
|
48,987
|
0.02%
|
|
Nov 30, 2024
|
Calamos Advisors Llc
|
48,987
|
0.02%
|
|
Oct 31, 2024
|
Calamos Advisors Llc
|
48,987
|
0.02%
|
|
Sep 30, 2024
|
Calamos Advisors Llc
|
45,244
|
0.02%
|
Sep 30, 2024
|
Calamos Advisors Llc
|
50,096
|
0.02%
|
|
Aug 31, 2024
|
Calamos Advisors Llc
|
50,096
|
0.02%
|
|
Jul 31, 2024
|
Calamos Advisors Llc
|
50,237
|
0.02%
|
|
Jun 30, 2024
|
Calamos Advisors Llc
|
46,433
|
0.02%
|
Jun 30, 2024
|
Calamos Advisors Llc
|
51,928
|
0.02%
|
|
May 31, 2024
|
Calamos Advisors Llc
|
51,928
|
0.02%
|
|
Apr 30, 2024
|
Calamos Advisors Llc
|
72,972
|
0.03%
|
|
Mar 31, 2024
|
Calamos Advisors Llc
|
48,124
|
0.02%
|
Mar 31, 2024
|
Calamos Advisors Llc
|
74,448
|
0.03%
|
|
Feb 29, 2024
|
Calamos Advisors Llc
|
74,448
|
0.03%
|
|
Jan 31, 2024
|
Calamos Advisors Llc
|
75,440
|
0.03%
|
|
Dec 31, 2023
|
Calamos Advisors Llc
|
69,172
|
0.03%
|
Dec 31, 2023
|
Calamos Advisors Llc
|
75,440
|
0.03%
|
|
Nov 30, 2023
|
Calamos Advisors Llc
|
75,440
|
0.03%
|
|
Oct 31, 2023
|
Calamos Advisors Llc
|
75,440
|
0.03%
|
|
Sep 30, 2023
|
Calamos Advisors Llc
|
70,095
|
0.03%
|
Sep 30, 2023
|
Calamos Advisors Llc
|
75,440
|
0.03%
|
|
Aug 31, 2023
|
Calamos Advisors Llc
|
75,440
|
0.03%
|
|
Jul 31, 2023
|
Calamos Advisors Llc
|
76,366
|
0.03%
|
|
Jun 30, 2023
|
Calamos Advisors Llc
|
70,095
|
0.03%
|
Jun 30, 2023
|
Calamos Advisors Llc
|
88,053
|
0.03%
|
|
May 31, 2023
|
Calamos Advisors Llc
|
88,113
|
0.03%
|
|
Mar 31, 2023
|
Calamos Advisors Llc
|
81,572
|
0.03%
|
View all ownership details of Vertex Pharmaceuticals, Inc.